News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
330,779 Results
Type
Article (16046)
Company Profile (104)
Press Release (314621)
Multimedia
Podcasts (49)
Webinars (16)
Section
Business (108958)
Career Advice (371)
Deals (17905)
Drug Delivery (52)
Drug Development (38160)
Employer Resources (59)
FDA (5808)
Job Trends (7778)
News (169515)
Policy (11893)
Tag
Academia (1444)
Academic (1)
Accelerated approval (5)
Adcomms (2)
Allergies (41)
Alliances (38596)
ALS (74)
Alzheimer's disease (861)
Antibody-drug conjugate (ADC) (125)
Approvals (5899)
Artificial intelligence (292)
Autoimmune disease (21)
Automation (17)
Bankruptcy (157)
Best Places to Work (6637)
BIOSECURE Act (12)
Biosimilars (74)
Biotechnology (82)
Bladder cancer (36)
Brain cancer (21)
Breast cancer (237)
Cancer (1925)
Cardiovascular disease (128)
Career advice (327)
Career pathing (15)
CAR-T (119)
CDC (10)
Cell therapy (338)
Cervical cancer (14)
Clinical research (31580)
Collaboration (1098)
Company closure (3)
Compensation (232)
Complete response letters (13)
COVID-19 (1207)
CRISPR (55)
C-suite (308)
Cystic fibrosis (67)
Data (1799)
Decentralized trials (2)
Denatured (30)
Depression (44)
Diabetes (177)
Diagnostics (3145)
Digital health (17)
Diversity (9)
Diversity, equity & inclusion (17)
Drug discovery (148)
Drug pricing (51)
Drug shortages (8)
Duchenne muscular dystrophy (86)
Earnings (34462)
Editorial (17)
Employer branding (4)
Employer resources (55)
Events (49260)
Executive appointments (620)
FDA (6882)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (4)
Funding (808)
Gene editing (97)
Generative AI (23)
Gene therapy (270)
GLP-1 (406)
Government (1782)
Guidances (193)
Healthcare (9758)
HIV (34)
Huntington's disease (15)
IgA nephropathy (27)
Immunology and inflammation (125)
Immuno-oncology (11)
Indications (17)
Infectious disease (1310)
Inflammatory bowel disease (92)
Inflation Reduction Act (8)
Influenza (49)
Intellectual property (99)
Interviews (37)
IPO (8016)
IRA (18)
Job creations (1404)
Job search strategy (283)
Kidney cancer (7)
Labor market (23)
Layoffs (200)
Leadership (10)
Legal (2129)
Liver cancer (42)
Longevity (7)
Lung cancer (277)
Lymphoma (136)
Machine learning (14)
Management (25)
Manufacturing (350)
MASH (48)
Medical device (5437)
Medtech (5448)
Mergers & acquisitions (10394)
Metabolic disorders (439)
Multiple sclerosis (55)
NASH (9)
Neurodegenerative disease (97)
Neuropsychiatric disorders (25)
Neuroscience (1326)
NextGen: Class of 2025 (3619)
Non-profit (2895)
Now hiring (15)
Obesity (198)
Opinion (118)
Ovarian cancer (73)
Pain (67)
Pancreatic cancer (76)
Parkinson's disease (128)
Partnered (27)
Patents (178)
Patient recruitment (122)
Peanut (17)
People (31403)
Pharmaceutical (22)
Pharmacy benefit managers (2)
Phase I (10601)
Phase II (13965)
Phase III (10190)
Pipeline (1531)
Policy (86)
Postmarket research (684)
Preclinical (4558)
Press Release (55)
Prostate cancer (97)
Psychedelics (10)
Radiopharmaceuticals (162)
Rare diseases (281)
Real estate (2960)
Recruiting (20)
Regulatory (9404)
Reports (14)
Research institute (1485)
Resumes & cover letters (51)
Rett syndrome (9)
RNA editing (11)
RSV (19)
Schizophrenia (57)
Series A (149)
Series B (105)
Service/supplier (5)
Sickle cell disease (39)
Special edition (5)
Spinal muscular atrophy (100)
Sponsored (20)
Startups (2699)
Stomach cancer (7)
Supply chain (55)
Tariffs (31)
The Weekly (18)
Vaccines (427)
Venture capital (47)
Weight loss (113)
Women's health (29)
Worklife (3)
Date
Last 7 days (321)
Last 30 days (1219)
Last 365 days (17421)
2025 (11724)
2024 (19586)
2023 (22674)
2022 (27676)
2021 (30452)
2020 (28643)
2019 (25259)
2018 (18810)
2017 (16663)
2016 (15331)
2015 (18051)
2014 (12590)
2013 (9656)
2012 (10401)
2011 (11024)
2010 (9716)
Location
Africa (328)
Alabama (54)
Alaska (7)
Arizona (91)
Arkansas (7)
Asia (21872)
Australia (3608)
California (4498)
Canada (1385)
China (543)
Colorado (207)
Connecticut (234)
Delaware (174)
Europe (50405)
Florida (583)
Georgia (159)
Hawaii (2)
Idaho (31)
Illinois (358)
India (29)
Indiana (285)
Iowa (9)
Japan (206)
Kansas (40)
Kentucky (14)
Louisiana (12)
Maine (55)
Maryland (677)
Massachusetts (3398)
Michigan (124)
Minnesota (243)
Mississippi (4)
Missouri (80)
Montana (23)
Nebraska (6)
Nevada (55)
New Hampshire (25)
New Jersey (1146)
New Mexico (26)
New York (1199)
North Carolina (640)
North Dakota (9)
Northern California (2106)
Ohio (125)
Oklahoma (10)
Oregon (17)
Pennsylvania (854)
Puerto Rico (3)
Rhode Island (24)
South America (431)
South Carolina (26)
South Dakota (1)
Southern California (1625)
Tennessee (107)
Texas (675)
United States (16424)
Utah (137)
Virginia (124)
Washington D.C. (23)
Washington State (344)
West Virginia (4)
Wisconsin (44)
330,779 Results for "tetra discovery partners".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Enhanced Genomics and the ALBORADA Drug Discovery Institute Partner to Accelerate Alzheimer’s Drug Discovery
June 24, 2025
·
2 min read
I&I
Novartis Drops up to $1B+ for Drug Discovery Deal With Matchpoint
The partnership with Matchpoint Therapeutics gets Novartis global rights on all molecules for several unannounced inflammatory diseases identified through the biotech’s discovery platform.
July 24, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
NVIDIA Partners With Novo Nordisk and DCAI to Advance Drug Discovery
June 11, 2025
·
6 min read
Press Releases
OPTIC and Mechanica Partners Expand Strategic Collaboration to Power AI-Driven Venture Creation Across Multiple Programs
Collaboration highlights Mechanica Partners’ innovative use of Optic’s BIOPTIC platform to bridge scientific discovery and strategic business insights for accelerated biotech portfolio growth
June 6, 2025
·
1 min read
Earnings
Terns Seeks Partners for Metabolic Assets Amid Oversaturated Obesity Market
Terns, once a rising star in obesity and the MASH space, will refocus on cancer and partner out a handful of obesity assets.
August 6, 2025
·
2 min read
·
Annalee Armstrong
Press Releases
Parallel Bio Secures $21 Million in Series A to Advance Human-First Drug Discovery
Signs on Eight Pharmaceutical Partners and Completes First Preclinical Study from Immune Organoid Platform with Centivax
June 12, 2025
·
1 min read
Neuroscience
Novartis, BioArctic Partner To Penetrate the Blood-Brain Barrier
Novartis has bet up to $772 million to gain access to BioArctic’s BrainTransporter platform, which was leveraged in a partnership with Eisai to produce Leqembi.
August 27, 2025
·
1 min read
·
Tristan Manalac
Genetown
Labforward Joins the Tetra Partner Network to Eliminate Data Silos and Error-Prone Data Transfers
TetraScience, the Scientific Data Cloud company, announced today that Labforward, a leader in optimizing laboratory workflows, has joined the Tetra Partner Network to enable scientists to maximize the value of their data utilizing the Tetra Scientific Data Cloud™.
January 12, 2023
·
3 min read
Schizophrenia
Atai-Partnered Schizophrenia Drug Flunks Mid-Stage Trial
Despite the failure of its Recognify-partnered inidascamine, Jefferies analysts do not expect a definitively negative stock impact on atai, given the company’s promising psychedelic pipeline.
July 28, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Unlocking the Potential of Cyclic Peptide Therapeutics: Viva Biotech’s Discovery Insights
September 2, 2025
·
4 min read
1 of 33,078
Next
